NDC 71872-7294-01 - Naloxone Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 71872-7294
- Requested NDC
- 71872-7294-01
- Package NDCs from labels
- 71872-7294-1, 71872-7294-01
- Manufacturer
- Medical Purchasing Solutions, LLC
- Effective date
- 2023-04-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Naloxone Hydrochloride - Medical Purchasing Solutions, LLC | Medical Purchasing Solutions, LLC | 2023-04-24 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71872-7294-1 | Naloxone Hydrochloride | 2 mL in 1 SYRINGE | INJECTION | 2 | 3 | |
| 71872-7294-1 | Naloxone Hydrochloride | 1 in 1 BAG | INJECTION | 1 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 71872-7294 | NALOXONE HYDROCHLORIDE INJECTION [MEDICAL PURCHASING SOLUTIONS, LLC] | 3 | Current NDC, Legacy NDC, 2 package rows | 20230425_ea4ea2fe-af48-0b3c-e053-2a95a90a0ad5.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| NALOXONE HYDROCHLORIDE | NALOXONE HYDROCHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | 3ba53405-5e72-c035-e063-6294a90ac0b1 | 2025-08-05 | Warnings, Adverse reactions | F850569PQR |
| Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | Fresenius Kabi USA, LLC | 201fdedf-1736-4e52-9d7d-de14292547fd | 2025-07-31 | Warnings, Adverse reactions | 1191250 F850569PQR |
| Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | ProPharma Distribution | 3856ea66-29b8-8fc2-e063-6394a90ac33a | 2025-07-18 | Warnings, Adverse reactions | F850569PQR |
| Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | Eugia US LLC | 8bcf426a-b4fc-4f24-9ad0-fb26168a0b56 | 2025-05-14 | Warnings, Adverse reactions | 1191250 F850569PQR |
| naloxone hydrochloride | NALOXONE HYDROCHLORIDE | NorthStar RxLLC | d4c44b74-4e36-4b63-80eb-64ce99ccb39f | 2025-01-27 | Warnings, Adverse reactions | F850569PQR |
| Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | Henry Schein, Inc. | d39635a4-ddb3-4d32-8211-eb84c78e9f59 | 2025-01-27 | Warnings, Adverse reactions | F850569PQR |
| NALOXONE HYDROCHLORIDE | NALOXONE HYDROCHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | 9bcff682-1196-7cef-e053-2a95a90aa954 | 2025-01-08 | Warnings, Adverse reactions | F850569PQR |
| Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | International Medication Systems, Limited | 236349ef-2cb5-47ca-a3a5-99534c3a4996 | 2024-12-16 | Warnings, Adverse reactions | ANDA072076 76329-1469 1191250 2db33194-380a-4dd5-ba87-abdad14209bd 236349ef-2cb5-47ca-a3a5-99534c3a4996 F850569PQR |
| Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | 28f3e3bc-b1be-9f06-e063-6394a90a1936 | 2024-12-10 | Warnings, Adverse reactions | F850569PQR |
| Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | Asclemed USA, Inc. | 7acf3bde-f858-4fbc-8a11-6741a3d27b8e | 2024-10-29 | Warnings | F850569PQR |
| naloxone hydrochloride | NALOXONE HYDROCHLORIDE | Baxter Healthcare Corporation | 48137634-91d7-41e3-b54b-e4321d69668a | 2024-10-04 | Warnings, Adverse reactions | 1191250 F850569PQR |
| NALOXONE HYDROCHLORIDE | NALOXONE HYDROCHLORIDE | Bryant Ranch Prepack | ed549649-dcbd-41f7-a774-876906751c5a | 2024-10-03 | Warnings | F850569PQR |
| Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | Eugia US LLC | c7fa8d4f-28a7-4ef5-aef8-cbd4328ce599 | 2024-07-06 | Warnings, Adverse reactions | F850569PQR |
| NALOXONE HYDROCHLORIDE | NALOXONE HYDROCHLORIDE | Eugia US LLC | 2725b9c0-5b1e-498b-9ec5-ee76a62e656a | 2024-07-06 | Warnings, Adverse reactions | F850569PQR |
| NALOXONE HYDROCHLORIDE | NALOXONE HYDROCHLORIDE | Advanced Rx of Tennessee, LLC | 1be2e38b-55ca-abea-e063-6394a90ac548 | 2024-06-27 | Warnings | F850569PQR |
| NALOXONE HYDROCHLORIDE | NALOXONE HYDROCHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | 19b0603b-241f-f439-e063-6294a90ae85f | 2024-05-30 | Warnings | F850569PQR |
| Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | CVS Pharmacy, Inc | 840e017d-0142-4d0e-a80e-327ac44bc0c5 | 2024-04-24 | Warnings | F850569PQR |
| Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | Walgreen Co. | 3829826b-e48f-4e26-869f-6b9e4ee0a840 | 2024-04-24 | Warnings | F850569PQR |
| Naloxone Hydrochloride | NALOXONE | Amneal Pharmaceuticals NY LLC | 8779a073-dc6e-410a-9959-fd370f0079f9 | 2024-04-19 | Warnings | F850569PQR |
| Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | Mylan Institutional LLC | 7faaedb3-227b-408d-b772-6b326638b00e | 2024-04-12 | Warnings, Adverse reactions | 1191250 F850569PQR |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.